Evidence map›Paper›PMID 36426547›Full record

ArticleTechnology in cancer research & treatment

High Expression of Folate Receptor Alpha (FOLR1) is Associated With Aggressive Tumor Behavior, Poor Response to Chemoradiotherapy, and Worse Survival in Rectal Cancer.

Chih-I Chen, Wan-Shan Li, Hsin-Pao Chen, Kuang-Wen Liu, Chia-Jen Tsai, Wei-Ju Hung, Ching-Chieh Yang

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Intraoperative molecular imaging of colorectal lung metastases with SGM-101: a feasibility study.European journal of nuclear medicine and molecular imaging · 2024
    Trial
  2. Folate receptor alpha in platinum-resistant ovarian cancer: prevalence in a multicenter Polish cohort and review of the evidence.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Folate Receptor Alpha-A Novel Approach to Cancer Therapy.International journal of molecular sciences · 2024
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Chih-I ChenDivision of Colon and Rectal Surgery, Department of Surgery, 63344E-DA Hospital, Kaohsiung.
Wan-Shan LiInstitute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung.
Hsin-Pao ChenDivision of Colon and Rectal Surgery, Department of Surgery, 63344E-DA Hospital, Kaohsiung.
Kuang-Wen LiuDivision of Colon and Rectal Surgery, Department of Surgery, 63344E-DA Hospital, Kaohsiung.
Chia-Jen TsaiDepartment of Radiation Oncology, 38018Chi Mei Medical Center, Tainan.
Wei-Ju HungDepartment of Radiation Oncology, 38018Chi Mei Medical Center, Tainan.
Ching-Chieh YangDepartment of Radiation Oncology, 38018Chi Mei Medical Center, Tainan.ORCID 0000-0003-3823-4673
Chi Mei Medical Center · TWE-Da Hospital · TWChung Hwa University of Medical Technology · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Folate Receptor 1Rectal NeoplasmsBiomarkers, TumorChemoradiotherapyHumansPrognosisRetrospective StudiesBiomarkers, TumorFolate Receptor 1FOLR1 protein, humanchemoradiationfolate receptor alpharectal cancerresponsesurvival

Identifiers

PMID36426547
PMCPMC9703519
OpenAlexW4310457951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.